Skip to main content
Livermore
Livermore
ZHEN

CVS Health Corp

SEC CIK
0000064803
Latest filing
Aug 6, 2026

The latest 13F from CVS Health Corp covers Q2 2026 (filed Aug 6, 2026): 21 long positions worth $225.2M. The top 10 holdings make up 83.7% of the portfolio, and the largest is iShares Tr at 20.7%. Livermore has 19 filings on Form 13F from this institution, going back to Q4 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
4
Est. +$16.1M
Added
7
Est. +$69.9M
Reduced
1
Est. −$4.47M
Sold out
16
Est. −$69.0M

Top 5 holdings

Share of this quarter's portfolio value

  1. iShares Tr464288646
    20.7%$46.6M
  2. iShares Tr464288638
    10.4%$23.4M
  3. iShares Tr464288661
    9.5%$21.5M
  4. iShares Tr464287457
    9.4%$21.2M
  5. iShares Tr46435U853
    7.9%$17.7M

Share of portfolio

Top 5 holdings and the other 16 positions, by share of portfolio value

  1. iShares Tr20.7%
  2. iShares Tr10.4%
  3. iShares Tr9.5%
  4. iShares Tr9.4%
  5. iShares Tr7.9%
  6. Other 16 positions42.1%

Biggest buys

New and added positions, by estimated amount bought

  1. iShares Tr464288646
    +$31.2MAdded
  2. iShares Tr464288638
    +$18.5MAdded
  3. iShares Iboxx $ Investment Grade Corporate Bond ETF464287242
    +$7.63MNew
  4. iShares Tr464288513
    +$7.20MNew
  5. iShares Tr464288281
    +$7.04MAdded

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. iShares Tr464288646
    +13.43 pp7.3% → 20.7%
  2. iShares Tr464288638
    +8.06 pp2.3% → 10.4%
  3. iShares Iboxx $ Investment Grade Corporate Bond ETF464287242
    +3.39 pp0.0% → 3.4%
  4. iShares Tr464288513
    +3.20 pp0.0% → 3.2%
  5. iShares Tr464288281
    +2.97 pp4.7% → 7.7%

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. SPYSPDR S&P 500 ETF Trust
    −$57.0MSold outHistory
  2. Invesco Exchange Traded FD T46137V357
    −$4.47MReduced
  3. State Street Health Care Select Sector SPDR ETF81369Y209
    −$1.76MSold out
  4. Vanguard Ftse Developed Markets ETF921943858
    −$1.28MSold out
  5. State Street Utilities Select Sector SPDR ETF81369Y886
    −$1.15MSold out

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. SPYSPDR S&P 500 ETF Trust
    −26.83 pp26.8% → 0.0%History
  2. Invesco Exchange Traded FD T46137V357
    −1.89 pp2.1% → 0.2%
  3. State Street Health Care Select Sector SPDR ETF81369Y209
    −0.83 pp0.8% → 0.0%
  4. Vanguard Ftse Developed Markets ETF921943858
    −0.60 pp0.6% → 0.0%
  5. State Street Utilities Select Sector SPDR ETF81369Y886
    −0.54 pp0.5% → 0.0%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$225.2M
+$12.9M (+6.1%) vs. prior quarter
Positions
21
−12 vs. prior quarter
Top 10 concentration
83.7%
Top 10 as share of value
Turnover
33.6%
Q2 2026, one quarter
Average holding period
2.4 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2021), so positions held before then are understated.

13F filings by quarter

19 quarters, going back to Q4 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $233.7M (Q4 2024)

Q4 2021: $64.6MQ1 2022: $115.7MQ2 2022: $120.6MQ3 2022: $98.6MQ4 2022: $111.2MQ1 2023: $165.5MQ2 2023: $190.8MQ3 2023: $185.7MQ4 2023: $193.4MQ1 2024: $211.8MQ2 2024: $216.8MQ3 2024: $230.2MQ4 2024: $233.7MQ1 2025: $172.7MQ2 2025: $190.6MQ3 2025: $102.9MQ4 2025: $135.3MQ1 2026: $212.3MQ2 2026: $225.2M
Q4 2021Q2 2026
13F filings of CVS Health Corp by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 6, 202621$225.2MiShares TriShares TriShares Trvs. Q1 2026SEC
Q1 2026May 7, 202633$212.3MSPYiShares TriShares Trvs. Q4 2025SEC
Q4 2025Feb 13, 20269$135.3MSPYiShares TriShares Trvs. Q3 2025SEC
Q3 2025Oct 31, 20253$102.9MSPYPRUHCATvs. Q2 2025SEC
Q2 2025Aug 1, 20253$190.6MSPYPRUHCATvs. Q1 2025SEC
Q1 2025May 2, 20253$172.7MSPYPRUHCATvs. Q4 2024SEC
Q4 2024Feb 13, 20253$233.7MSPYPRUHCATvs. Q3 2024SEC
Q3 2024Nov 8, 20245$230.2MSPYVanguard High Dividend Yield Index ETFiShares Core High Dividend ETFvs. Q2 2024SEC
Q2 2024Aug 9, 20246$216.8MSPYVanguard High Dividend Yield Index ETFiShares Core High Dividend ETFvs. Q1 2024SEC
Q1 2024May 3, 20246$211.8MSPYVanguard High Dividend Yield Index ETFiShares Core High Dividend ETFvs. Q4 2023SEC
Q4 2023Feb 9, 20246$193.4MSPYVanguard High Dividend Yield Index ETFiShares Core High Dividend ETFvs. Q3 2023SEC
Q3 2023Nov 3, 20239$185.7MSPYiShares Core High Dividend ETFVanguard High Dividend Yield Index ETFvs. Q2 2023SEC
Q2 2023Aug 4, 20239$190.8MSPYiShares Core High Dividend ETFVanguard High Dividend Yield Index ETFvs. Q1 2023SEC
Q1 2023May 5, 20239$165.5MSPYiShares Core High Dividend ETFVanguard High Dividend Yield Index ETFvs. Q4 2022SEC
Q4 2022Feb 10, 20236$111.2MiShares Core High Dividend ETFVanguard High Dividend Yield Index ETFSchwab US Dividend Equity ETFvs. Q3 2022SEC
Q3 2022Nov 10, 20227$98.6MiShares Core High Dividend ETFVanguard High Dividend Yield Index ETFSchwab US Dividend Equity ETFvs. Q2 2022SEC
Q2 2022Aug 12, 20226$120.6MiShares Core High Dividend ETFVanguard High Dividend Yield Index ETFSchwab US Dividend Equity ETFvs. Q1 2022SEC
Q1 2022May 13, 20226$115.7MiShares Core High Dividend ETFVanguard High Dividend Yield Index ETFSchwab US Dividend Equity ETFvs. Q4 2021SEC
Q4 2021May 13, 20224$64.6MiShares Core High Dividend ETFHCATPRU–SEC